Megan Sterchi Lammert Quoted in Lexology PRO Article Regarding AI-Enabled Medical Devices
Baker Sterchi Member Megan Sterchi Lammert is quoted in a Lexology PRO article titled “Monitoring AI-enabled medical devices is easier said than done, public consultation reveals,” discussing the FDA’s request for public input on how to measure the real-world performance of AI-enabled medical devices.
Lammert notes that clients should maintain a proactive and flexible compliance strategy as regulations continue to develop. She adds that updates from the FDA, local authorities and key global regulators should be closely monitored to ensure prompt adaptation as rules change.
Sterchi Lammert focuses her practice on personal injury, premises liability and product liability defense. She serves as a steering committee member and regional chair of the ALFA International Product Liability & Complex Torts Practice Group. She has been selected for inclusion in Best Lawyers: Ones to Watch in America in the Kansas City Metropolitan Area for her work in personal injury and product liability, as well as Missouri & Kansas Super Lawyers: Rising Stars for her work in personal injury. She earned her law degree from the University of Missouri and is licensed in Missouri and Kansas.
Lexology is a global legal intelligence platform offering insights, analysis and guidance from leading law firms worldwide. The complete article can be found
here (subscription required).
trending ATTORNEYS on baker sterchi
